We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Publishes Product-Specific Guideline for Biosimilar Heparin
EMA Publishes Product-Specific Guideline for Biosimilar Heparin
The development process for biosimilar heparins no longer requires a comparative clinical trial, according to new guidance from the European Medicines Agency.